Metropolitan Life Insurance Company (MetLife)’s Precigen PGEN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,837	Closed	-$4.11K	–	1543
2024 Q1	$4.11K	Buy	2,837 +1,661	+141%	+$2.38K	﹤0.01%	2258
2023 Q4	$1.58K	Sell	1,176 -5,631	-83%	-$6.62K	﹤0.01%	2328
2023 Q3	$9.67K	Hold	6,807	–	–	﹤0.01%	2224
2023 Q2	$7.83K	Hold	6,807	–	–	﹤0.01%	2403
2023 Q1	$7.21K	Buy	6,807 +493	+8%	+$711	﹤0.01%	2246
2022 Q4	$9.6K	Buy	6,314 +162	+3%	+$279	﹤0.01%	2292
2022 Q3	$13K	Buy	+6,152	New	+$13K	﹤0.01%	2215
2022 Q1	–	Sell	-15,392	Closed	-$57.1K	–	2569
2021 Q4	$57.1K	Sell	15,392 -1,687	-10%	-$7.26K	﹤0.01%	2687
2021 Q3	$85.2K	Sell	17,079 -8,218	-32%	-$47.3K	﹤0.01%	2611
2021 Q2	$165K	Buy	25,297 +5,378	+27%	+$37.6K	﹤0.01%	2291
2021 Q1	$137K	Buy	19,919 +1,158	+6%	+$9.79K	﹤0.01%	2268
2020 Q4	$191K	Sell	18,761 -574	-3%	-$3.72K	﹤0.01%	1969
2020 Q3	$67.7K	Sell	19,335 -5,732	-23%	-$27.2K	﹤0.01%	2418
2020 Q2	$125K	Sell	25,067 -735	-3%	-$2.5K	﹤0.01%	2121
2020 Q1	$87.7K	Buy	25,802 +2,630	+11%	+$11.3K	﹤0.01%	2109
2019 Q4	$127K	Sell	23,172 -657	-3%	-$3.7K	﹤0.01%	2186
2019 Q3	$136K	Hold	23,829	–	–	﹤0.01%	2131
2019 Q2	$183K	Hold	23,829	–	–	﹤0.01%	1946
2019 Q1	$125K	Sell	23,829 -363	-2%	-$2.52K	﹤0.01%	2189
2018 Q4	$158K	Buy	24,192 +1,052	+5%	+$11.8K	﹤0.01%	1962
2018 Q3	$398K	Hold	23,140	–	–	0.01%	1526
2018 Q2	$323K	Buy	23,140 +19,136	+478%	+$323K	0.01%	1606
2018 Q1	$61.4K	Buy	4,004 +250	+7%	+$3.57K	﹤0.01%	2427
2017 Q4	$43K	Sell	3,754 -48	-1%	-$715	﹤0.01%	2473
2017 Q3	$72K	Buy	3,802 +607	+19%	+$12.5K	﹤0.01%	2433
2017 Q2	$77K	Sell	3,195 -604	-16%	-$13.2K	﹤0.01%	2528
2017 Q1	$75K	Sell	3,799 -34	-0.9%	-$759	﹤0.01%	2464
2016 Q4	$92K	Sell	3,833 -173	-4%	-$4.82K	﹤0.01%	2543
2016 Q3	$111K	Sell	4,006 -192	-5%	-$5.08K	﹤0.01%	2539
2016 Q2	$102K	Buy	4,198 +505	+14%	+$14.3K	﹤0.01%	2593
2016 Q1	$124K	Hold	3,693	–	–	﹤0.01%	2403
2015 Q4	$110K	Buy	3,693 +286	+8%	+$9.64K	﹤0.01%	2491
2015 Q3	$107K	Hold	3,407	–	–	﹤0.01%	2575
2015 Q2	$165K	Sell	3,407 -25,688	-88%	-$1.08M	﹤0.01%	2498
2015 Q1	$1.26M	Hold	29,095	–	–	0.01%	1080
2014 Q4	$766K	Hold	29,095	–	–	0.01%	1496
2014 Q3	$517K	Hold	29,095	–	–	﹤0.01%	1701
2014 Q2	$699K	Buy	29,095 +16,286	+127%	+$330K	﹤0.01%	1590
2014 Q1	$322K	Hold	12,809	–	–	﹤0.01%	2113
2013 Q4	$291K	Hold	12,809	–	–	﹤0.01%	2203
2013 Q3	$290K	Buy	+12,809	New	+$296K	﹤0.01%	2133

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PGEN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Precigen (PGEN) in Q2 2024, closing a stake of 2,837 shares — an estimated $4.11K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PGEN in Q3 2013 and held it in 41 quarters. The position peaked at $1.26M in Q1 2015. 130 funds tracked by Wall St. Rank hold PGEN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Precigen position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,837 Precigen shares in Q2 2024, an estimated $4.11K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Precigen in Q3 2013 and held it in 41 quarters.
Metropolitan Life Insurance Company (MetLife)'s Precigen position peaked at $1.26M in Q1 2015.
130 funds tracked by Wall St. Rank held Precigen as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.